Lee Danner & Bass Inc. boosted its stake in Danaher Corporation (NYSE:DHR – Free Report) by 30.6% during the first quarter, according to the company in its most recent filing with the SEC. The fund owned 23,175 shares of the conglomerate’s stock after buying an additional 5,426 shares during the period. Lee Danner & Bass Inc.’s holdings in Danaher were worth $4,394,000 as of its most recent filing with the SEC.
Other large investors have also recently bought and sold shares of the company. Elevated Capital Advisors LLC acquired a new stake in Danaher during the fourth quarter worth approximately $26,000. Hilton Head Capital Partners LLC acquired a new position in shares of Danaher in the fourth quarter valued at approximately $27,000. Clal Insurance Enterprises Holdings Ltd grew its position in shares of Danaher by 71.6% in the fourth quarter. Clal Insurance Enterprises Holdings Ltd now owns 127 shares of the conglomerate’s stock valued at $29,000 after purchasing an additional 53 shares during the last quarter. JPL Wealth Management LLC bought a new position in shares of Danaher during the third quarter worth approximately $25,000. Finally, WFA of San Diego LLC bought a new position in shares of Danaher during the second quarter worth approximately $26,000. 79.05% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
Several research firms recently weighed in on DHR. Citigroup assumed coverage on Danaher in a report on Tuesday, May 26th. They set a “buy” rating and a $230.00 price target for the company. HSBC decreased their price objective on Danaher from $270.00 to $230.00 and set a “buy” rating on the stock in a report on Wednesday, June 3rd. The Goldman Sachs Group dropped their target price on Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a report on Monday, April 13th. Argus reduced their target price on shares of Danaher from $265.00 to $230.00 and set a “buy” rating for the company in a research report on Friday, April 24th. Finally, Evercore upped their price target on shares of Danaher from $225.00 to $232.00 and gave the company an “outperform” rating in a research note on Tuesday, April 21st. One analyst has rated the stock with a Strong Buy rating, nineteen have issued a Buy rating, four have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Danaher has an average rating of “Moderate Buy” and a consensus target price of $233.61.
Danaher Stock Down 0.0%
NYSE DHR opened at $197.85 on Friday. The company has a current ratio of 1.87, a quick ratio of 1.52 and a debt-to-equity ratio of 0.33. The company has a market cap of $140.03 billion, a price-to-earnings ratio of 38.27, a PEG ratio of 2.52 and a beta of 0.79. The company has a 50 day moving average of $179.01 and a 200-day moving average of $200.54. Danaher Corporation has a 1-year low of $160.93 and a 1-year high of $242.80.
Danaher (NYSE:DHR – Get Free Report) last issued its quarterly earnings results on Monday, April 20th. The conglomerate reported $2.06 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.94 by $0.12. Danaher had a return on equity of 10.91% and a net margin of 14.89%.The business had revenue of $5.95 billion for the quarter, compared to the consensus estimate of $6 billion. During the same quarter in the prior year, the business posted $1.88 earnings per share. The firm’s quarterly revenue was up 3.7% compared to the same quarter last year. On average, equities research analysts expect that Danaher Corporation will post 8.44 earnings per share for the current fiscal year.
Danaher Dividend Announcement
The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Stockholders of record on Friday, June 26th will be issued a dividend of $0.40 per share. This represents a $1.60 annualized dividend and a dividend yield of 0.8%. The ex-dividend date of this dividend is Friday, June 26th. Danaher’s dividend payout ratio is 30.95%.
Danaher Company Profile
Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.
Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.
Featured Articles
- Five stocks we like better than Danaher
- These Stocks Could Win as Wall Street Looks Beyond AI Software
- D.R. Horton Is Defying the Housing Gloom
- Why Flywire and Airbnb Could Be Quiet Winners of a Ceasefire
- Broadcom and OpenAI Unveil JalapeƱo: An Early Step to Massive AI Growth Potential
Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.
